ArticleThe breast journal2023

Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome.

Khaled Abd Elaziz Ahmed Elnaghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.